Skip to content
Disclosery

RP Management, LLC

Follow

13F filer, CIK 1507673, New York, NY

RP Management, LLC reported $103,613,165 across 3 holdings for the quarter ended 2023-09-30, in a 13F-HR filed 2023-11-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001507673-23-000019

Period
2023-09-30
Reported value
$104M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2023

Share positions as resolved from 13F-HR 0001507673-23-000019, largest first. % of portfolio is the value over $103,613,165, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: 2,936,507 shares 2,936,507$76.4M73.72%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: 3,846,154 shares 3,846,154$27.2M26.28%0Timeline
VIRACTA THERAPEUTICS INCVIRACTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: 3,700 shares 3,700$3.85K<0.01%0

How Q3 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001507673-23-000019 base2023-11-13acceptance time not in the bulk data set